NO20000514L - Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav - Google Patents

Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav

Info

Publication number
NO20000514L
NO20000514L NO20000514A NO20000514A NO20000514L NO 20000514 L NO20000514 L NO 20000514L NO 20000514 A NO20000514 A NO 20000514A NO 20000514 A NO20000514 A NO 20000514A NO 20000514 L NO20000514 L NO 20000514L
Authority
NO
Norway
Prior art keywords
virus
hepatitis
methods
hcv
hiv
Prior art date
Application number
NO20000514A
Other languages
English (en)
Other versions
NO20000514D0 (no
NO328535B1 (no
Inventor
Kevin M Gorman
David R Patterson
Jeffrey M Linnen
Keming Song
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of NO20000514D0 publication Critical patent/NO20000514D0/no
Publication of NO20000514L publication Critical patent/NO20000514L/no
Publication of NO328535B1 publication Critical patent/NO328535B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20000514A 1999-02-03 2000-02-01 Fremgangsmate for multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) samt kit for slik multipleksdeteksjon NO328535B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11849899P 1999-02-03 1999-02-03

Publications (3)

Publication Number Publication Date
NO20000514D0 NO20000514D0 (no) 2000-02-01
NO20000514L true NO20000514L (no) 2000-08-04
NO328535B1 NO328535B1 (no) 2010-03-15

Family

ID=22378976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000514A NO328535B1 (no) 1999-02-03 2000-02-01 Fremgangsmate for multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) samt kit for slik multipleksdeteksjon

Country Status (13)

Country Link
US (1) US6623919B1 (no)
EP (1) EP1035220B1 (no)
JP (1) JP5442917B2 (no)
KR (1) KR100910545B1 (no)
CN (1) CN1213150C (no)
AT (1) ATE264925T1 (no)
AU (1) AU783171C (no)
CA (1) CA2296044C (no)
DE (1) DE60009977T2 (no)
DK (1) DK1035220T3 (no)
ES (1) ES2218067T3 (no)
NO (1) NO328535B1 (no)
PT (1) PT1035220E (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4824236B2 (ja) * 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるｈｉｖ−１の検出
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
EP2251442B9 (en) 2003-12-19 2012-04-25 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2147118A4 (en) * 2007-04-27 2010-09-01 Eragen Biosciences Inc MATERIALS AND METHOD FOR DETECTING HEPATITIS C VIRUS
WO2010013017A1 (en) * 2008-07-31 2010-02-04 Oxitec Limited Multiplex amplification and detection
CN104120194B (zh) * 2014-08-08 2016-05-18 卫生部北京医院 一种病毒rna检测引物的设计方法及试剂盒
WO2016137975A1 (en) 2015-02-23 2016-09-01 University Of Washington Primers, probes and methods for sensitive, specific detection and monitoring of hiv-1 and hcv
CN106011309A (zh) * 2016-05-20 2016-10-12 凯杰生物工程（深圳）有限公司 用于检测人丙型肝炎病毒的引物组和探针
WO2018045425A1 (en) * 2016-09-07 2018-03-15 St Vincent's Hospital Sydney Limited Methods of detecting lentivirus
CN110892082A (zh) * 2017-10-03 2020-03-17 雅培分子公司 丙型肝炎病毒(hcv)的测定

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US5491225A (en) * 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
US5747244A (en) 1991-12-23 1998-05-05 Chiron Corporation Nucleic acid probes immobilized on polystyrene surfaces
DE69324678T2 (de) * 1992-11-27 1999-12-09 Naamloze Vennootschap Innogenetics S.A., Gent Verfahren zur typisierung von hcv-isolaten
IT1284847B1 (it) * 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
ES2218067T3 (es) 2004-11-16
EP1035220A3 (en) 2001-08-22
JP5442917B2 (ja) 2014-03-19
AU783171C (en) 2006-07-13
NO20000514D0 (no) 2000-02-01
KR20000076598A (ko) 2000-12-26
AU1482800A (en) 2000-08-03
PT1035220E (pt) 2004-09-30
KR100910545B1 (ko) 2009-08-03
DK1035220T3 (da) 2004-08-16
ATE264925T1 (de) 2004-05-15
US6623919B1 (en) 2003-09-23
NO328535B1 (no) 2010-03-15
CN1213150C (zh) 2005-08-03
CA2296044A1 (en) 2000-08-03
AU783171B2 (en) 2005-09-29
CN1268575A (zh) 2000-10-04
EP1035220B1 (en) 2004-04-21
JP2000279198A (ja) 2000-10-10
CA2296044C (en) 2009-01-13
DE60009977D1 (de) 2004-05-27
EP1035220A2 (en) 2000-09-13
DE60009977T2 (de) 2005-08-04

Similar Documents

Publication Publication Date Title
DK1026263T3 (da) Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf
NO20000536D0 (no) Oligonukleotidprimere for effektiv deteksjon av Hepatitis C- virus (HCV) og metoder for anvendelse derav
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
NO20000514L (no) Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav
DK0854197T3 (da) Primere til påvisning af HIV-1
ATE386821T1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
ATE142276T1 (de) Nukleotid-sequenzen nützlich als typenspezifische sonden, pcr primers und lcr sonden zur amplifikation und zum nachweis von humanem papillomavirus, sowie dazu verwendete kits und verfahren
IS5900A (is) Greining í tilraunaglasi (in vitro) á virkni DNA fjölliðuensíms lifrarbílgu B veiru í mönnum (HBV),og notkun hennar við skimun eftir hemlum DNA fjölliðuensíms HBV
ATE305522T1 (de) Nachweis von humanen papillomviren
NO20000537D0 (no) Oligonukleotidprimere for effektiv reverstranskripsjon av Hepatitis C-virus (HCV) RNA og metoder for anvendelse derav
WO2002022781A3 (en) Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
이두식 et al. Detection of human immunodeficiency virus (HIV) type 1 provial sequences of peripheral blood mononuclear cells by using polymerase chain reaction
FR2621816B1 (fr) Application antivirale des ologonucleotides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees